9월6일(목) 의대 BK21plus 사업단 – 화학과 대학원 BK21plus 사업단 공동 세미나 Professor Bing Zhang(Department of Molecular and Human Genetics; Lester and Sue Smith Breast Center, Baylor College of Medicine)
|초청강사||Professor Bing Zhang|
|소속||Department of Molecular and Human Genetics; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston|
|일시||2018년 9월 6일(목) 오후 5시|
|장소||하나스퀘어 지하1층 대강당|
Proteogenomic characterization of human colon cancer reveals novel therapeutic opportunities
We performed an unprecedented characterization of human colon cancer and paired normal samples with comprehensive integration of data from seven omics platforms. We confirmed previously described benefits of protegenomic integration in human cancer studies and further demonstrated its utility in revealing novel therapeutic opportunities. Comparative proteomic and phosphoproteomic analyses of paired tumor and adjacent normal samples produced a comprehensive catalogue of colon cancer-associated proteins, phosphosites, and kinase activities, including known and putative biomarkers, drug targets, and cancer-testis (CT) antigens. Proteogenomic integration not only prioritized genomically inferred targets such as somatic copy number drivers and somatic mutation-derived neoantigens, but also yielded unexpected discovery of signaling and metabolic targets for specific colon cancers.
Designed by sketchbooks.co.kr / sketchbook5 board skin